Rana McKay, MD
Enriched profileProfessor, Departments of Radiation Medicine & Applied Sciences, Medicine, and Urology; Associate Director of Clinical Science, Moores Cancer Center, UC San Diego · University of California, San Diego
Rana McKay is Professor, Departments of Radiation Medicine & Applied Sciences, Medicine, and Urology; Associate Director of Clinical Science, Moores Cancer Center, UC San Diego at University of California, San Diego. OpenAlex indexes 1,247 publications with 15,963 citations (h-index 58); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 16 Oct 2026
Rana McKay, MD, is Professor, Departments of Radiation Medicine & Applied Sciences, Medicine, and Urology at University of California, San Diego (UC San Diego Health / Moores Cancer Center). The public record shows 1,247 publications with 15,963 citations (h-index 58), centered on Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 34 companies, 2 NIH-funded awards (2025–2026).
- Most recent indexed publication: 2026 · Nature
- Top research focus: Prostate Cancer Treatment and Research
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 92 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 245.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Sponsor: GlaxoSmithKline
- Retifanlimab and Ruxolitinib In Solid Malignancies
Sponsor: University of California, San Diego
Industry payments
Updated 16 Oct 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year202517 payments$21,238openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202520 payments$15,114openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20255 payments$13,613openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
50%Cytochrome P450 17A1 Inhibitor21.3%Abiraterone Acetate100%Part D≥12 patientsGonadotropin Releasing Hormone Receptor Antagonist14.4%Orgovyx100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
27.2%Corticosteroid27.2%Prednisone100%Part D≥27 patientsNervous system
8.9%Phenothiazine8.9%Prochlorperazine Maleate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2025–2026 per NIH RePORTER. The latest:
- Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell Carcinoma
University of California, San Diego
FY2025$2,984,495R01CA292799
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.
Journal for immunotherapy of cancer
Clinical Trial2026 - Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).
Journal of clinical oncology
Clinical Trial2026 - The seventh kidney cancer research summit: progress in accelerating cures.
The oncologist
Conference Proceedings2026
Most-cited works
by citation count (OpenAlex)- 01Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study1,802 citations2020
- 02
- 04NCCN Guidelines Insights: Prostate Cancer, Version 1.2021530 citations2021
- 05NCCN Task Force Report: Bone Health in Cancer Care412 citations2013
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/rana-mckay-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/rana-mckay-5b84321bb
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
profiles.ucsd.edu/rana.mckay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu ↗ - ResearchGate
researchgate.net/profile/Rana-Mckay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/DrRanaMcKay
Mentions by others
where others cite or feature them- Other
hem-onc.ucsd.edu/about/faculty.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hem-onc.ucsd.edu ↗ - Other
providers.ucsd.edu/details/32684/medical-oncology-cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - Other
radonc.ucsd.edu/faculty/applied-sciences/mckay-rana.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Other
backtable.com/shows/urology/contributors/dr-rana-mckay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com ↗ - Other
kidneycancer.org/qa-rana-mckay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidneycancer.org ↗ - LinkedIn
linkedin.com/posts/moores-cancer-center_moores-member-rana-mckay-md-has-contributed-activity-7437887931035381761-mbcT
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/oncodaily_sumanta-pal-with-my-co-lead-rana-mckay-activity-7165933165088391168-L4RS
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
onclive.com/authors/rana-mckay-md-university-of-california-san-diego
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Florida College of Medicine, Gainesville
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Residency
Internal Medicine, Johns Hopkins Hospital, Baltimore, MD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Fellowship
Oncology/Hematology, Dana-Farber Cancer Institute, Harvard Medical School, Cambridge, MA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Principal Investigator
NIH R01CA292799, "Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell Carcinoma"
2029verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu ↗ - Associate Director of Clinical Science
Moores Cancer Center, UC San Diego
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Co-leader
Genitourinary Oncology Disease Team, Moores Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗ - Leads multidisciplinary prostate cancer clinic
Moores Cancer Center, UC San Diego Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Secondary affiliations
appointments beyond the home institution- Department of Medicine
UC San Diego School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Department of Urology
UC San Diego School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsd.edu ↗ - Genitourinary Oncology
Division of Medical Oncology (Hematology-Oncology faculty), UC San Diego
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hem-onc.ucsd.edu ↗ - Formerly Assistant Professor
Harvard Medical School, and medical oncologist, Dana-Farber/Brigham and Women's Cancer Center, Boston (prior to UC San Diego)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncbrothers.com ↗
- Guest
BackTable Urology Podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com ↗ - Video panel
"The Southern California Research Forum: Advancing GU Cancer Care" with Monty Pal, UroToday
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗ - Video interview
"Rana McKay, MD, on persistence and adherence to relugolix for prostate cancer", Urology Times
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urologytimes.com ↗ - Recurring contributor/author
OncLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Recurring contributor/author
Targeted Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗ - Profile feature
"Inside UC San Diego's Research Program with Dr. Rana McKay", KidneyCAN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidneycan.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ravindra Mehta, MD
University of California, San Diego
Barry Greenberg, MD
University of California, San Diego
Anthony Demaria, MD
University of California, San Diego
Arthur Kavanaugh, MD
University of California, San Diego
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)